<DOC>
	<DOCNO>NCT02392364</DOCNO>
	<brief_summary>The purpose study compare safety efficacy intravitreal Eylea injection set interval , versus variable dosing schedule ( likely longer one month ) , base specific individual 's disease progression . There approximately 50 men woman least 18 year age , diagnose type 1 type 2 diabetes , take part study 5 location United States .</brief_summary>
	<brief_title>Variable Interval Versus Set Interval Aflibercept DME</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>1 . Adults 18 year old Type 1 Type 2 diabetes mellitus 2 . Patients diabetic macular edema involve center macular study eye ( CST must measure least 350µm Heidelberg SDOCT , 333µm Cirrus SDOCT ) 3 . Decrease vision determine primarily due DME study eye 4 . BCVA ETDRS letter score 78 24 ( 20/32 20/320 ) study eye 5 . Willing able comply clinical visit study related procedure 6 . Willing able provide sign informed consent 1 . History vitreoretinal surgery study eye 2 . Laser photocoagulation ( panretinal macular ) study eye within 90 day baseline 3 . Previous use intraocular periocular corticosteroid study eye within 90 day baseline 4 . History intravitreal antiVEGF treatment study within 90days prior baseline ( include prior intravitreal aflibercept injection [ see exclusion criterion # 5 ] ) 5 . Any history intravitreal aflibercept 6 . Active proliferative diabetic retinopathy ( PDR ) study eye 7 . History idiopathic autoimmune uveitis study eye 8 . Cataract surgery study eye within 90 day baseline 9 . Aphakia study eye 10 . Yttrium aluminum garnet ( YAG ) capsulotomy study eye within 30 day baseline 11 . Any intraocular surgery study eye within 90 day day 1 12 . Vitreomacular traction epiretinal membrane study eye think affect central vision 13 . Current iris neovascularization , vitreous hemorrhage , traction retinal detachment study eye 14 . Preretinal fibrosis involve macula study eye 15 . Uncontrolled glaucoma ( defined patient filtration surgery past , likely need filtration surgery future , IOP ≥30mmHg ) 16 . Myopia spherical equivalent prior possible refractive cataract surgery ≥8 diopter 17 . Concurrent disease study eye , DME , could compromise BCVA , require medical surgical intervention study period , could confound interpretation result ( include retinal vascular occlusion , retinal detachment , macular hole , choroidal neovascularization cause ) 18 . Ocular medium insufficient quality obtain fundus SDOCT image 19 . Current treatment systemic infection 20 . Administration systemic antiangiogenic agent within 180 day baseline 21 . Uncontrolled diabetes mellitus , opinion investigator 22 . Uncontrolled blood pressure ( define systolic &gt; 180mmHg , diastolic &gt; 110mmHg patient sit ) 23 . History CVA MI within 180 day baseline 24 . Renal failure require dialysis renal transplant 25 . Known serious allergy fluorescein 26 . Participation investigational study within 30 day prior baseline involve treatment drug ( exclude vitamin mineral ) device 27 . Any woman pregnant , breastfeeding , attempt become pregnant 28 . Sexually active men* woman childbearing potential** unwilling practice adequate contraception study ( adequate contraceptive measure include stable use oral contraceptive prescription pharmaceutical contraceptive 2 menstrual cycle prior screen ; intrauterine device [ IUD ] ; bilateral tubal ligation ; vasectomy ; condom plus contraceptive sponge , foam , jelly , diaphragm plus contraceptive sponge , foam , jelly ) *Contraception require men document vasectomy . **Postmenopausal woman must amenorrheic least 12 month order consider child bear potential . Pregnancy test contraception require woman document hysterectomy tubal ligation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>